#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Sarit Aharoni Email
Research Assistant . Chemomab
,
LocationPrimary Email
How to contact Sarit Aharoni
Join and see Sarit's contact info for free!Current Roles
Employees:
33Revenue:
$6.6MAbout
Chemomab Ltd. is a clinical-stage biotech company, focusing on discovery and development of innovative therapeutics for fibrosis-related diseases. Chemomab is making great strides with its novel CM-101 proprietary platform, which hinders the fundamental function of the soluble chemokine CCL24 as a regulator of major inflammatory and fibrotic pathways in multiple fibrosis-related disorders. CM-101, the company's lead clinical candidate, is a first-in-class monoclonal antibody that targets CCL24. Chemomab has shown that CM-101 interferes with the underlying biology of fibrosis using a novel and differentiated mechanism of action. Chemomab is actively advancing CM-101 into phase 2 studies to treat patients with liver fibrosis (Primary Sclerosing Cholangitis and Non-alcoholic Steatohepatitis) and patients suffering from skin and lung fibrosis (Systemic Sclerosis).Chemomab Address
Kiryat Atidim, Building 7null, null